神经保护和视力恢复的细胞和亚细胞光遗传学方法。

IF 18.6 1区 医学 Q1 OPHTHALMOLOGY Progress in Retinal and Eye Research Pub Date : 2023-09-01 DOI:10.1016/j.preteyeres.2022.101153
Edward H. Wood , Alexander Kreymerman , Tia Kowal , David Buickians , Yang Sun , Stephanie Muscat , Mark Mercola , Darius M. Moshfeghi , Jeffrey L. Goldberg
{"title":"神经保护和视力恢复的细胞和亚细胞光遗传学方法。","authors":"Edward H. Wood ,&nbsp;Alexander Kreymerman ,&nbsp;Tia Kowal ,&nbsp;David Buickians ,&nbsp;Yang Sun ,&nbsp;Stephanie Muscat ,&nbsp;Mark Mercola ,&nbsp;Darius M. Moshfeghi ,&nbsp;Jeffrey L. Goldberg","doi":"10.1016/j.preteyeres.2022.101153","DOIUrl":null,"url":null,"abstract":"<div><p><span><span><span>Optogenetics<span> is defined as the combination of genetic and optical methods to induce or inhibit well-defined events in isolated cells, tissues, or animals. While optogenetics within ophthalmology has been primarily applied towards treating inherited </span></span>retinal disease<span>, there are a myriad of other applications that hold great promise for a variety of eye diseases including cellular regeneration, modulation of mitochondria and metabolism, regulation of </span></span>intraocular pressure<span><span>, and pain control. Supported by primary data from the authors’ work with in vitro and in vivo applications, we introduce a novel approach to metabolic regulation, Opsins to Restore Cellular ATP (ORCA). We review the fundamental constructs for </span>ophthalmic optogenetics, present current therapeutic approaches and </span></span>clinical trials<span><span>, and discuss the future of subcellular and signaling pathway applications for </span>neuroprotection and vision restoration.</span></p></div>","PeriodicalId":21159,"journal":{"name":"Progress in Retinal and Eye Research","volume":null,"pages":null},"PeriodicalIF":18.6000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247900/pdf/","citationCount":"1","resultStr":"{\"title\":\"Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration\",\"authors\":\"Edward H. Wood ,&nbsp;Alexander Kreymerman ,&nbsp;Tia Kowal ,&nbsp;David Buickians ,&nbsp;Yang Sun ,&nbsp;Stephanie Muscat ,&nbsp;Mark Mercola ,&nbsp;Darius M. Moshfeghi ,&nbsp;Jeffrey L. Goldberg\",\"doi\":\"10.1016/j.preteyeres.2022.101153\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span><span>Optogenetics<span> is defined as the combination of genetic and optical methods to induce or inhibit well-defined events in isolated cells, tissues, or animals. While optogenetics within ophthalmology has been primarily applied towards treating inherited </span></span>retinal disease<span>, there are a myriad of other applications that hold great promise for a variety of eye diseases including cellular regeneration, modulation of mitochondria and metabolism, regulation of </span></span>intraocular pressure<span><span>, and pain control. Supported by primary data from the authors’ work with in vitro and in vivo applications, we introduce a novel approach to metabolic regulation, Opsins to Restore Cellular ATP (ORCA). We review the fundamental constructs for </span>ophthalmic optogenetics, present current therapeutic approaches and </span></span>clinical trials<span><span>, and discuss the future of subcellular and signaling pathway applications for </span>neuroprotection and vision restoration.</span></p></div>\",\"PeriodicalId\":21159,\"journal\":{\"name\":\"Progress in Retinal and Eye Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":18.6000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247900/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Retinal and Eye Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1350946222001136\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Retinal and Eye Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1350946222001136","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 1

摘要

光遗传学被定义为遗传和光学方法的结合,以在分离的细胞、组织或动物中诱导或抑制明确的事件。虽然眼科中的光遗传学主要应用于治疗遗传性视网膜疾病,但还有许多其他应用对各种眼病有很大的前景,包括细胞再生、线粒体和代谢的调节、眼压的调节和疼痛控制。在作者体外和体内应用工作的主要数据的支持下,我们介绍了一种新的代谢调节方法,即Opsins恢复细胞ATP(ORCA)。我们综述了眼科光遗传学的基本结构,介绍了目前的治疗方法和临床试验,并讨论了亚细胞和信号通路在神经保护和视力恢复中的应用前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration

Optogenetics is defined as the combination of genetic and optical methods to induce or inhibit well-defined events in isolated cells, tissues, or animals. While optogenetics within ophthalmology has been primarily applied towards treating inherited retinal disease, there are a myriad of other applications that hold great promise for a variety of eye diseases including cellular regeneration, modulation of mitochondria and metabolism, regulation of intraocular pressure, and pain control. Supported by primary data from the authors’ work with in vitro and in vivo applications, we introduce a novel approach to metabolic regulation, Opsins to Restore Cellular ATP (ORCA). We review the fundamental constructs for ophthalmic optogenetics, present current therapeutic approaches and clinical trials, and discuss the future of subcellular and signaling pathway applications for neuroprotection and vision restoration.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
34.10
自引率
5.10%
发文量
78
期刊介绍: Progress in Retinal and Eye Research is a Reviews-only journal. By invitation, leading experts write on basic and clinical aspects of the eye in a style appealing to molecular biologists, neuroscientists and physiologists, as well as to vision researchers and ophthalmologists. The journal covers all aspects of eye research, including topics pertaining to the retina and pigment epithelial layer, cornea, tears, lacrimal glands, aqueous humour, iris, ciliary body, trabeculum, lens, vitreous humour and diseases such as dry-eye, inflammation, keratoconus, corneal dystrophy, glaucoma and cataract.
期刊最新文献
The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health. Editorial Board Optical coherence tomography angiography of the retina and choroid in systemic diseases The AI revolution in glaucoma: Bridging challenges with opportunities Value proposition of retinal imaging in Alzheimer's disease screening: A review of eight evolving trends
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1